Key facts
- This page summarizes Robert Kramer's Form 4 filing for Emergent BioSolutions Inc. (EBS).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 24 Feb 2022, 17:56.
Robert Kramer - 22 Feb 2022 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)
- Reporting relationship
- President and CEO, Director
- Issuer ticker
- EBS
- Reported as of
- 22 Feb 2022
- Net transaction value
- -$194,047
- SEC form
- 4
- Accepted by SEC
- 24 Feb 2022, 17:56:56 UTC
- Prior SEC filing
- 11 May 2021
- Next SEC filing
- 25 Feb 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ S. Scott Lieberman, Attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Robert Kramer filed Form 4 for Emergent BioSolutions Inc. (EBS) on 24 Feb 2022.
Change
- Previous filing in this sequence was filed on 11 May 2021.
- Current net transaction value: -$194,047.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
EBS
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +4,264
- Change %
- +2.6%
- Price
- $0.000000
- Shares after
- 167,317
- Date
- 22 Feb 2022
- Ownership
- Direct
- Footnotes
- F1
EBS
transaction
Common Stock
Tax liability
- Transaction value
- $194,047
- Shares
- -4,595
- Change %
- -2.7%
- Price
- $42.23
- Shares after
- 162,722
- Date
- 22 Feb 2022
- Ownership
- Direct
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2021 fiscal year, as certified by the Compensation Committee following the performance period. On February 22, 2022, the final certification date, the Compensation Committee certified the achievement of the 2019-2021 PSUs at a payout factor of 136.14% of target resulting in the actual award of 16,065 shares of common stock, which is in excess of the 11,801 shares previously reported on February 28, 2019.
Footnote F2
Represents shares of common stock withheld to pay taxes.